📣 VC round data is live. Check it out!

Sopharma Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sopharma and similar public comparables like BioLife Solutions, Shinva, Gerresheimer, Kestra Medical Technologies and more.

Sopharma Overview

About Sopharma

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.


Founded

1933

HQ

Bulgaria

Employees

5.6K

Financials (FY)

Revenue: $2B
EBITDA: $156M

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Sopharma Financials

Sopharma reported last fiscal year revenue of $2B and EBITDA of $156M.

In the same fiscal year, Sopharma generated $368M in gross profit, $156M in EBITDA, and $78M in net income.

Revenue (LTM)


Sopharma P&L

In the most recent fiscal year, Sopharma reported revenue of $2B and EBITDA of $156M.

Sopharma is profitable as of last fiscal year, with gross margin of 23%, EBITDA margin of 10%, and net margin of 5%.

See analyst estimates for Sopharma
Last FY202320242025202620272028
Revenue$2B$1B$1B$2B
Gross Profit$368M$245M$274M$368M
Gross Margin23%22%21%23%
EBITDA$156M$107M$100M$156M
EBITDA Margin10%9%8%10%
EBIT Margin6%5%4%6%
Net Profit$78M$58M$46M$78M
Net Margin5%5%4%5%
Net Debt$254M

Financial data powered by Morningstar, Inc.

Sopharma Stock Performance

Sopharma has current market cap of $1B, and enterprise value of $1B.

Market Cap Evolution


Sopharma's stock price is $2.16.

Sopharma share price increased by 6.9% in the last 30 days, and decreased by 72.2% in the last year.

Sopharma has an EPS (earnings per share) of $0.15.

See more trading valuation data for Sopharma
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$1B-0.0%6.9%-1.1%-72.2%$0.15

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Sopharma Valuation Multiples

Sopharma trades at 0.7x EV/Revenue multiple, and 7.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Sopharma

EV / Revenue (LTM)


Sopharma Financial Valuation Multiples

As of May 23, 2026, Sopharma has market cap of $1B and EV of $1B.

Sopharma has a P/E ratio of 14.6x.

Last FY202320242025202620272028
EV/Revenue0.7x1.0x0.9x0.7x
EV/EBITDA7.3x10.6x11.3x7.3x
EV/EBIT12.9x19.2x21.7x12.9x
EV/Gross Profit3.1x4.6x4.1x3.1x
P/E14.6x19.6x24.7x14.6x
EV/FCF(15.2x)n/m(42.1x)(15.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Sopharma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Sopharma Margins & Growth Rates

In the most recent fiscal year, Sopharma reported gross margin of 23%, EBITDA margin of 10%, and net margin of 5%.

See estimated margins and future growth rates for Sopharma

Sopharma Margins

Last FY20242025202720282029
Gross Margin23%21%23%
EBITDA Margin10%8%10%
EBIT Margin6%4%6%
Net Margin5%4%5%
FCF Margin(5%)(2%)(5%)

Sopharma Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth14%23%
Gross Profit Growth12%34%
EBITDA Growth(6%)56%
EBIT Growth(12%)69%
Net Profit Growth(20%)69%
FCF Growth(2659%)178%

Data powered by FactSet, Inc. and Morningstar, Inc.

Sopharma Operational KPIs

Sopharma's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Sopharma
Last FY202320242025202620272028
Revenue per Employee$0.3M
Opex per Employee$0.1M
S&M Expenses to Revenue2%2%2%2%
G&A Expenses to Revenue1%1%1%1%
Opex to Revenue18%16%17%18%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Sopharma Competitors

Sopharma competitors include BioLife Solutions, Shinva, Gerresheimer, Kestra Medical Technologies, Paul Hartmann, Menicon, Arjo, Salus, Cerus and Chengzhi.

Most Sopharma public comparables operate across Medical Supplies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
BioLife Solutions11.5x10.7x44.5x41.2x
Shinva0.6x0.6x7.0x6.9x
Gerresheimer1.4x1.2x7.2x7.2x
Kestra Medical Technologies17.0x10.7x(12.8x)(12.2x)
Paul Hartmann0.4x3.9x
Menicon1.3x1.3x8.7x7.5x
Arjo0.6x0.6x3.7x3.7x
Salus0.7x17.1x

This data is available for Pro users. Sign up to see all Sopharma competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Sopharma

When was Sopharma founded?Sopharma was founded in 1933.
Where is Sopharma headquartered?Sopharma is headquartered in Bulgaria.
How many employees does Sopharma have?As of today, Sopharma has over 5K employees.
Is Sopharma publicly listed?Yes, Sopharma is a public company listed on Bulgarian Stock Exchange.
What is the stock symbol of Sopharma?Sopharma trades under SFA ticker.
When did Sopharma go public?Sopharma went public in 2000.
Who are competitors of Sopharma?Sopharma main competitors include BioLife Solutions, Shinva, Gerresheimer, Kestra Medical Technologies, Paul Hartmann, Menicon, Arjo, Salus, Cerus, Chengzhi.
What is the current market cap of Sopharma?Sopharma's current market cap is $1B.
What is the current revenue of Sopharma?Sopharma's last fiscal year revenue is $2B.
What is the current EV/Revenue multiple of Sopharma?Current revenue multiple of Sopharma is 0.7x.
Is Sopharma profitable?No, Sopharma is not profitable.
How many companies Sopharma has acquired to date?Sopharma hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Sopharma has invested to date?Sopharma hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Sopharma

Lists including Sopharma

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial